Attorney General Phil Weiser today joined a bipartisan coalition of 48 states and territories in announcing a $29.6 million settlement with Glenmark Pharmaceuticals to resolve allegations that the generic drug manufacturer participated in a widespread, long-running conspiracy to inflate prices, reduce competition, and restrain trade for numerous generic prescription drugs. Under the settlement, Colorado’s estimated share is $406,518.

“Generic drugs are supposed to make health care more affordable through competition, not become the subject of illegal price-fixing schemes. When companies conspire to manipulate prices, Colorado families, businesses, and public health programs all pay the price. This settlement holds Glenmark accountable, advances our ongoing case against other defendants, and reinforces that companies must compete fairly and follow the law.” – AG Weiser